Evidence map›Paper›PMID 25566345›Full record

ArticleJournal of vascular and interventional neurology2014

Effect of intra-arterial injection of lidocaine and methyl-prednisolone into middle meningeal artery on intractable headaches.

Adnan I Qureshi, Mushtaq H Qureshi, Asif A Khan, M Fareed K Suri

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of vascular and interventional neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07054801 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Intra-arterial Lidocaine and Methylprednisolone Injection Into the Middle Meningeal Artery For Treatment of Headache Associated With Subarachnoid Hemorrhage

TypeinterventionalSponsorDaniel Raper, MBBSRan2026 to 2027Enrolled25ConditionsHeadaches Associated With Subarachnoid Hemorrhage (SAH)ArmsLidocaine hydrochloride, Methylprednisolone sodium succinate
NCT07633067 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine: A Multicenter, Prospective, Double-blind, Multigroup, Randomized Controlled Trial.

TypeinterventionalSponsorThe Affiliated Hospital Of Guizhou Medical UniversityRan2026 to 2028Enrolled150ConditionsMigraineArmsMiddle meningeal artery embolization, Conventional standard pharmacotherapy for migraine
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Intra-arterial lidocaine therapy via the middle meningeal artery for migraine headache: Theory, current practice and future directions.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Review
  2. Article
  3. Chronic migraine and bilateral occlusion of the middle meningeal artery.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  4. Intra-arterial lidocaine administration of lidocaine in middle meningeal artery for short-term treatment of subarachnoid hemorrhage-related headaches.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  5. Middle meningeal artery embolization for migraine: A review.Surgical neurology international · 2025
    Review
  6. Therapeutic Use of the Newly Described "Artery of Qureshi".Journal of vascular and interventional neurology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Adnan I QureshiZeenat Qureshi Stroke Institute, Department of Cerebrovascular Diseases and Interventional Neurology, CentraCare Health System, 1406 6th Ave N, St Cloud, MN, USA.
Mushtaq H QureshiZeenat Qureshi Stroke Institute, Department of Cerebrovascular Diseases and Interventional Neurology, CentraCare Health System, 1406 6th Ave N, St Cloud, MN, USA.
Asif A KhanZeenat Qureshi Stroke Institute, Department of Cerebrovascular Diseases and Interventional Neurology, CentraCare Health System, 1406 6th Ave N, St Cloud, MN, USA.
M Fareed K SuriZeenat Qureshi Stroke Institute, Department of Cerebrovascular Diseases and Interventional Neurology, CentraCare Health System, 1406 6th Ave N, St Cloud, MN, USA.
CentraCare Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present report describes the effect of intra-arterial injection of a dose of 40 mg lidocaine and 20 mg methylprednisolone into the middle meningeal artery of two patients suffering from severe headaches. The effect of injection of lidocaine and methylprednisolone was short lasting with effect manifesting within 5 min and lasting 5-8 h after injection. Both patients reported improvement in headache intensity after 24 h post-procedure. Intra-arterial injection of lidocaine and methylprednisolone may represent another treatment strategy for headaches not responsive to standard treatment.

Identifiers

PMID25566345
PMCPMC4280869
OpenAlexW2145021432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.